Hantann virus vaccine(U.S. Army Medical Research and Development Command)(Hantann virus vaccine(U.S. Army Medical Research and Development Command))

概要

基本信息

药物类型

预防性疫苗

别名-

靶点-

作用机制

免疫刺激剂

治疗领域

感染

在研适应症-

非在研适应症

肾综合征出血热

原研机构

U S Army Medical Research & Development Command

在研机构-

非在研机构-

最高研发阶段无进展临床1期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 Hantann virus vaccine(U.S. Army Medical Research and Development Command) 相关的临床试验

NCT03718130 / Unknown status临床1期IIT

A Phase 1, Randomized Trial to Assess the Safety, Reactogenicity, and Immunogenicity of a Combination HTNV and PUUV DNA Vaccine Candidate Administered by Electroporation

To evaluate the safety and reactogenicity of the hantaan virus (HTNV), puumala virus (PUUV), and combination HTNV/PUUV DNA vaccine candidates delivered to healthy adults

开始日期2019-10-11

申办/合作机构

U S Army Medical Research & Development Command

100 项与 Hantann virus vaccine(U.S. Army Medical Research and Development Command) 相关的临床结果

登录后查看更多信息

100 项与 Hantann virus vaccine(U.S. Army Medical Research and Development Command) 相关的转化医学

登录后查看更多信息

100 项与 Hantann virus vaccine(U.S. Army Medical Research and Development Command) 相关的专利（医药）

登录后查看更多信息

100 项与 Hantann virus vaccine(U.S. Army Medical Research and Development Command) 相关的药物交易

登录后查看更多信息